Sexually transmitted infections are more common than most men assume, and a large share of them produce no obvious symptoms in the early stages. The quiet damage they can do to the reproductive tract, however, is well documented. A single untreated chlamydia infection can scar the epididymis badly enough to block sperm from ever leaving the testicle. The mechanism is straightforward: bacteria travel up the urethra, colonise the delicate tubing behind the testicles, and trigger an inflammatory response that leaves behind fibrotic tissue. The result is obstructive azoospermia, a condition where semen contains no sperm because the highway is physically closed.
Gonorrhea works through the same route. Neisseria gonorrhoeae invades the epithelial cells lining the epididymis and vas deferens. In a study of men with acute epididymitis, roughly half of the cases in young men were traced to chlamydia or gonorrhea (Tracy et al., Journal of Urology, 2008). Once the acute infection is cleared with antibiotics, the scarring does not always reverse. It is one of the few causes of male infertility that is entirely preventable with early detection and treatment.
How an infection changes sperm quality
The sperm that do get through can carry signatures of the infection. Chlamydia trachomatis does not just sit on the surface of sperm; it attaches and injects its proteins. A study of 642 men recruited from infertility clinics found that those with chlamydia IgA antibodies in seminal plasma had significantly worse sperm motility and more DNA fragmentation than men without those antibodies (Gallegos et al., Human Reproduction, 2008). The sperm DNA damage was roughly double in the antibody-positive group.
The mechanism proposed in the literature is oxidative stress. When the immune system attacks an intracellular pathogen like chlamydia, it releases reactive oxygen species. Sperm have limited DNA repair machinery; their tightly packed chromatin relies on antioxidant defences in the seminal plasma. An ongoing low-grade infection tips that balance, leading to sperm with broken DNA strands that still look normal under a basic microscope but fail to fertilise an egg properly.
Gonorrhea and other bacteria can produce similar oxidative damage. Even after the infection is cleared, the sperm production cycle takes about 74 days. That means any insult to the testicular environment can show up in a semen analysis for two to three months afterward.
The silent aftermath: antisperm antibodies
Another mechanism that rarely gets talked about is the production of antisperm antibodies. The blood-testis barrier normally keeps sperm sequestered from the immune system so the body does not recognise its own developing sperm as foreign. A severe epididymal infection or trauma can breach that barrier. Once the immune system encounters sperm antigens, it can start producing antibodies that coat sperm, causing them to clump together or lose the ability to penetrate the egg’s outer layer.
A review in Human Reproduction Update (Marconi et al., 2009) documented that men with post-infectious obstructive azoospermia often have elevated antisperm antibody levels. These antibodies can persist long after the original infection is gone, making conception difficult even when surgery successfully reopens the blocked tube.
Not just the classics: a wider cast of microbes
Chlamydia and gonorrhea are the heavy hitters, but they are not the only ones with a fertility footprint.
Trichomonas vaginalis, a common protozoan parasite often asymptomatic in men, has been associated with reduced sperm motility and viability in multiple studies. A meta-analysis of nine studies published in PLOS ONE (2014) reported that T. vaginalis infection was significantly linked to abnormal semen parameters.
Mycoplasma genitalium and Ureaplasma urealyticum, two bacteria that lack a cell wall and can fly under the radar of standard cultures, colonise the urethra and prostate. A 2022 systematic review in Andrology pooled data from 27 studies and found that Ureaplasma infection was associated with lower sperm concentration and motility, as well as higher DNA fragmentation. Importantly, several of the included studies showed that a course of appropriate antibiotics led to improvement in semen quality, which strengthens the case for causation.
HPV, the human papillomavirus, has been detected in semen and on sperm surfaces. A study of 109 couples undergoing IVF showed that when the male partner had HPV DNA in his semen, the rate of clinical pregnancy was lower, from around 38% to 14% (Garolla et al., Fertility and Sterility, 2012). The proposed mechanism is that HPV binds to the sperm head and impairs the acrosome reaction, the critical enzyme release that lets sperm penetrate the egg. The research is still developing, but the finding is plausible, given that HPV is an epithelial virus that thrives in the same kind of mucosal tissue found in the urethra.
HIV carries its own set of fertility challenges, partly from the virus itself and partly from the chronic inflammation that accompanies it. Untreated HIV infection is associated with hypogonadism, where the testes produce less testosterone, and with testicular atrophy (Rochira et al., Clinical Endocrinology, 2011). Modern antiretroviral therapy has largely normalised those outcomes, but testicular function does not always fully recover.
Syphilis and herpes simplex virus can also cause orchitis or epididymitis in rarer cases, though their main impact on fertility tends to be through systemic illness rather than direct genital tract damage.
What a man can actually do with this information
The takeaway is not that every STI will leave you infertile. The body’s repair systems are remarkably resilient, and early antibiotic treatment often preserves full function. The risk factor is time. The longer an infection goes untreated, the more scar tissue accumulates. Because symptoms can be absent or so mild they get ignored - a slight burning for a day, a little discharge that disappears - the gap between infection and diagnosis can stretch for months or years.
Screening protocols vary by country, but most sexual health guidelines recommend that sexually active men under 25, or men of any age with new or multiple partners, get tested for chlamydia and gonorrhea at least once a year. A urine nucleic acid amplification test (NAAT) catches these bacteria with high sensitivity and does not require a swab or blood draw. Many public health clinics offer it for free or low cost.
For men who have an existing semen analysis showing abnormal parameters and no other obvious cause, a thorough evaluation often includes a semen culture and PCR testing for the full panel of pathogens, including M. genitalium and Ureaplasma. The workup is worth doing because, as the studies above suggest, treating an occult infection can sometimes be the single intervention that improves sperm quality enough to allow natural conception or a successful IVF cycle.
None of this requires panic. It just requires knowing that the genital tract is not a sterile fortress; it is a living system, and a persistent infection in that system can remodel the architecture in ways that matter for fertility. The most effective tool is a straightforward test, and the second most effective is early treatment.
This content is for educational purposes only and is not medical advice. Oakman products are designed for physical comfort and cooling; they make no claims about fertility, sperm quality, or hormone levels. Consult a healthcare professional for personalized advice.